Literature DB >> 20667773

Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated comorbidities.

Sonia Maria Holanda Almeida Araujo1, Veralice Meireles Sales de Bruin, Lucas A Nepomuceno, Marcos Lelio Maximo, Elizabeth de Francesco Daher, Debora Praciano Correia Ferrer, Pedro Felipe Carvalhedo de Bruin.   

Abstract

BACKGROUND: Despite being frequently described in patients with end-stage renal disease (ESRD), clinical characteristics and comorbidities in association with restless legs syndrome (RLS) are still to be confirmed.
OBJECTIVES: The aim of this study was to investigate clinical factors associated with RLS in ESRD patients in hemodialysis.
METHODS: This is a cross-sectional study of 400 patients on hemodialysis, evaluating RLS, clinical features and other sleep abnormalities.
RESULTS: Out of 400, 86 patients presented RLS (21.5%; mean age 48.8+/-13.8y), being more frequent in females (p<0.005). Forty-eight individuals (12% mean age 50.7+/-13.1y) had moderate/severe RLS, 14 reported symptoms prior to hemodialysis, 13 described family history of RLS, and eight described symptoms as disturbing during dialysis. RLS cases showed lower hemoglobin (p<0.005), poorer quality of sleep (Pittsburgh Sleep Quality Index >5, p=0.002), higher scores on the Beck Depression Inventory Scale (p<0.005), greater scores on the Charlson Comorbidity Index (p=0.01) and the Epworth Sleepiness Scale (p=0.001) and higher risk of obstructive sleep apnea (OSA; Berlin questionnaire, p=0.01). Hypertension was more frequent in cases with moderate/severe RLS (p=0.01) and remained after controlling for the risk of OSA (p=0.02).
CONCLUSION: In ESRD patients in hemodialysis, RLS is present in 21.5%; 16% report symptoms prior to hemodialysis and a family history of RLS. Symptoms are disturbing during hemodialysis in 9% of cases. RLS is associated with lower hemoglobin, worse sleep quality, excessive daytime sleepiness, depressive symptoms and higher risk of OSA. Hypertension is associated with moderate/severe RLS. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20667773     DOI: 10.1016/j.sleep.2010.02.011

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  39 in total

Review 1.  Restless legs syndrome and pregnancy: prevalence, possible pathophysiological mechanisms and treatment.

Authors:  R Gupta; M Dhyani; T Kendzerska; S R Pandi-Perumal; A S BaHammam; P Srivanitchapoom; S Pandey; M Hallett
Journal:  Acta Neurol Scand       Date:  2015-10-19       Impact factor: 3.209

2.  Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  Giovanni Merlino; Simone Lorenzut; Giulio Romano; Martina Sommaro; Augusto Fontana; Domenico Montanaro; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2012-01-22       Impact factor: 3.307

3.  Uremia induces upregulation of cerebral tissue oxidative/inflammatory cascade, down-regulation of Nrf2 pathway and disruption of blood brain barrier.

Authors:  Wanghui Jing; Bahman Jabbari; Nosratola D Vaziri
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 4.  The Clinical Importance of Periodic Leg Movements in Sleep.

Authors:  Michela Figorilli; Monica Puligheddu; Patrizia Congiu; Raffaele Ferri
Journal:  Curr Treat Options Neurol       Date:  2017-03       Impact factor: 3.598

5.  Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort.

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Donald L Bliwise
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

6.  Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function.

Authors:  Willi Cawello; Sascha Ahrweiler; Wladyslaw Sulowicz; Agnieszka Szymczakiewicz-Multanowska; Marina Braun
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

7.  Cerebral blood flow alterations in hemodialysis patients with and without restless legs syndrome: an arterial spin labeling study.

Authors:  Hao Wang; Xue Han; Mei Jin; Li-Yan Wang; Zong-Li Diao; Wang Guo; Peng Zhang; Zheng Wang; Han Lv; He-Yu Ding; Zheng-Yu Zhang; Peng-Fei Zhao; Jing Li; Zheng-Han Yang; Wen-Hu Liu; Zhen-Chang Wang
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

8.  Diagnostic value of screening instruments for identifying obstructive sleep apnea in kidney failure.

Authors:  David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2013-01-15       Impact factor: 4.062

9.  The prevalence of restless legs syndrome across the full spectrum of kidney disease.

Authors:  Jonathan Lee; David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2013-05-15       Impact factor: 4.062

10.  The relationship between physical activity, restless legs syndrome, and health-related quality of life in type 2 diabetes.

Authors:  Thiago Medeiros da Costa Daniele; Veralice Meireles Sales de Bruin; Adriana Costa e Forte; Débora Siqueira Nobre de Oliveira; Clara Mota Randal Pompeu; Pedro Felipe Carvalhedo de Bruin
Journal:  Endocrine       Date:  2012-12-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.